许立哲, 余伟民, 饶婷, 李浩勇, 宁金卓, 程帆. miR-25靶向DKK3基因对前列腺癌PC-3细胞增殖、凋亡和迁移的影响[J]. 蚌埠医科大学学报, 2024, 49(4): 443-447. DOI: 10.13898/j.cnki.issn.1000-2200.2024.04.005
    引用本文: 许立哲, 余伟民, 饶婷, 李浩勇, 宁金卓, 程帆. miR-25靶向DKK3基因对前列腺癌PC-3细胞增殖、凋亡和迁移的影响[J]. 蚌埠医科大学学报, 2024, 49(4): 443-447. DOI: 10.13898/j.cnki.issn.1000-2200.2024.04.005
    XU Lizhe, YU Weimin, RAO Ting, LI Haoyong, NING Jinzhuo, CHENG Fan. Effect of miR-25 targeted regulation of DKK3 gene on the proliferation, apoptosis and migration of prostate cancer PC-3 cells[J]. Journal of Bengbu Medical University, 2024, 49(4): 443-447. DOI: 10.13898/j.cnki.issn.1000-2200.2024.04.005
    Citation: XU Lizhe, YU Weimin, RAO Ting, LI Haoyong, NING Jinzhuo, CHENG Fan. Effect of miR-25 targeted regulation of DKK3 gene on the proliferation, apoptosis and migration of prostate cancer PC-3 cells[J]. Journal of Bengbu Medical University, 2024, 49(4): 443-447. DOI: 10.13898/j.cnki.issn.1000-2200.2024.04.005

    miR-25靶向DKK3基因对前列腺癌PC-3细胞增殖、凋亡和迁移的影响

    Effect of miR-25 targeted regulation of DKK3 gene on the proliferation, apoptosis and migration of prostate cancer PC-3 cells

    • 摘要:
      目的 探讨miR-25靶向调控Dickkopf相关蛋白3(DKK3)基因对前列腺癌PC-3细胞增殖、凋亡和迁移的影响及其作用机制。
      方法 选取确诊并进行前列腺癌根治手术治疗的前列腺癌病人组织标本24例为研究对象, 选择同期因良性前列腺增生行电切手术病人组织标本24例为对照组, 采用HE染色观察2组前列腺组织形态学变化,实时定量PCR检测组织中miR-25的相对表达水平, 免疫组织化学法检测组织中DKK3表达情况。体外培养人前列腺癌PC-3细胞,通过Lipofectamine 2000法将miR-25 NC(NC组)、miR-25 inhibitors(miR-25 inhibitors组) 转染入PC-3细胞中,通过MTT实验检测miR-25对细胞增殖的影响,通过Transwell实验检测miR-25对PC-3细胞迁移能力的影响,通过流式细胞术检测miR-25对PC-3细胞凋亡的影响,Western blotting法检测转染后PC-3细胞中DKK3的蛋白表达水平。
      结果 前列腺癌组织较前列腺增生组织中miR-25表达水平显著升高(P < 0.05),DKK3基因表达明显降低(P < 0.05)。与NC组相比,miR-25 inhibitors组细胞增殖率显著降低(P < 0.05),细胞迁移能力显著降低(P < 0.01),细胞凋亡率显著升高(P < 0.01),DKK3的蛋白及mRNA表达水平显著升高(P < 0.05)。
      结论 miR-25通过靶向调控DKK3基因促进前列腺癌PC-3细胞的增殖和迁移,抑制细胞凋亡。

       

      Abstract:
      Objective To investigate the effects of miR-25 targeted regulation of DKK3 gene on the proliferation, apoptosis and migration of prostate cancer PC-3 cells and its mechanism.
      Methods A total of 24 patients with prostate cancer who were diagnosed and treated by radical prostatectomy were selected as the study subjects, and 24 patients with benign prostatic hyperplasia who underwent electrosurgical resection at the same time were selected as the control group.The morphological changes of prostate tissue in two groups were observed by HE staining.Real-time quantitative polymerase chain reaction was used to detect the expression of miR-25 in tissues.The expression of DKK3 in tissues was detected by immunohistochemistry.Human prostate cancer PC-3 cells were cultured in vitro, miR-25 NC (NC group) and miR-25 inhibitors (miR-25 inhibitors group) were transfected into PC-3 cells by Lipofectamine 2000, the effect of miR-25 on cells proliferation was detected by MTT assay, the migration of PC-3 cells were detected by Transwell assay, the effect of miR-25 on PC-3 cells apoptosis was detected by flow cytometry, and Western blotting was used to detect DKK3 protein expression in PC-3 cells after transfection.
      Results The expression of miR-25 in prostate cancer was significantly higher than that in benign prostatic hyperplasia (P < 0.05), and the expression of DKK3 was significantly lower (P < 0.05).Compared with the NC group, the proliferation rate of cells in the miR-25 inhibitors group was significantly decreased (P < 0.05), the ability of cells migration was significantly reduced (P < 0.01), the apoptosis rate was significantly increased (P < 0.01), and the expression level of DKK3 was significantly increased (P < 0.05).
      Conclusions MiR-25 promotes the proliferation and migration of prostate cancer PC-3 cells and inhibits apoptosis by targeting DKK3.

       

    /

    返回文章
    返回